These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8338481)

  • 21. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
    Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
    Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammographic screening in older women. Is it worthwhile?
    van Dijck JA; Broeders MJ; Verbeek AL
    Drugs Aging; 1997 Feb; 10(2):69-79. PubMed ID: 9061265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammography in symptomatic and asymptomatic patients.
    Stomper PC; Gelman RS
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screen-detected mucinous breast carcinoma: potential for delayed diagnosis.
    Dhillon R; Depree P; Metcalf C; Wylie E
    Clin Radiol; 2006 May; 61(5):423-30. PubMed ID: 16679116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Using mammographic density to improve breast cancer screening outcomes.
    Kavanagh AM; Byrnes GB; Nickson C; Cawson JN; Giles GG; Hopper JL; Gertig DM; English DR
    Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2818-24. PubMed ID: 18843028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Ernster V
    JAMA; 1996 Jul; 276(1):39-43. PubMed ID: 8667537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mammographic density and risk of breast cancer by tumor characteristics: a case-control study.
    Krishnan K; Baglietto L; Stone J; McLean C; Southey MC; English DR; Giles GG; Hopper JL
    BMC Cancer; 2017 Dec; 17(1):859. PubMed ID: 29246131
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk stratification of women with false-positive test results in mammography screening based on mammographic morphology and density: A case control study.
    Winkel RR; Euler-Chelpin MV; Lynge E; Diao P; Lillholm M; Kallenberg M; Forman JL; Nielsen MB; Uldall WY; Nielsen M; Vejborg I
    Cancer Epidemiol; 2017 Aug; 49():53-60. PubMed ID: 28558329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interval breast cancers in New South Wales, Australia, and comparisons with trials and other mammographic screening programmes.
    Taylor R; Supramaniam R; Rickard M; Estoesta J; Moreira C
    J Med Screen; 2002; 9(1):20-5. PubMed ID: 11943793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monitoring interval cancers in an Australian mammographic screening programme.
    Kavanagh AM; Mitchell H; Farrugia H; Giles GG
    J Med Screen; 1999; 6(3):139-43. PubMed ID: 10572844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
    May DS; Lee NC; Nadel MR; Henson RM; Miller DS
    AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Opportunistic mammography screening provides effective detection rates in a limited resource healthcare system.
    Teh YC; Tan GH; Taib NA; Rahmat K; Westerhout CJ; Fadzli F; See MH; Jamaris S; Yip CH
    BMC Cancer; 2015 May; 15():405. PubMed ID: 25972043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial.
    Nixon RM; Pharoah P; Tabar L; Krusemo UB; Duffy SW; Prevost TC; Chen HH
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):325-31. PubMed ID: 11011299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Breast cancer screening of women aged 70-74 years: results from a natural experiment across Australia.
    Nickson C; Mason KE; Kavanagh AM
    Breast Cancer Res Treat; 2014 Jan; 143(2):367-72. PubMed ID: 24327331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positive predictive value of screening mammography by age and family history of breast cancer.
    Kerlikowske K; Grady D; Barclay J; Sickles EA; Eaton A; Ernster V
    JAMA; 1993 Nov; 270(20):2444-50. PubMed ID: 8230621
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
    Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
    Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer in Singapore: some perspectives.
    Jara-Lazaro AR; Thilagaratnam S; Tan PH
    Breast Cancer; 2010; 17(1):23-8. PubMed ID: 19701678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The significance of mammographic calcifications in early breast cancer detection.
    Rosselli Del Turco M; Ciatto S; Bravetti P; Pacini P
    Radiol Med; 1986; 72(1-2):7-12. PubMed ID: 3008222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of early diagnosis and treatment in women with a family history of breast cancer. European Familial Breast Cancer Collaborative Group.
    Møller P; Reis MM; Evans G; Vasen H; Haites N; Anderson E; Steel CM; Apold J; Lalloo F; Maehle L; Preece P; Gregory H; Heimdal K
    Dis Markers; 1999 Oct; 15(1-3):179-86. PubMed ID: 10595275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.